RPRX (STOCKS)
Royalty Pharma plc Class A Ordinary Shares
$44.800000
+0.550000 (+1.24%)
Prev close: $44.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pablo Gerardo Legorreta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25,874.03M
- Employees
- 99
- P/E (TTM)
- 24.84
- P/B (TTM)
- 2.93
- Dividend Yield
- 198.87%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.46 | $1.35 | +0.1075 | +7.95% |
|
Sep 2025 (Q3)
|
$1.17 | $1.06 | +0.1063 | +9.99% |
|
Jun 2025 (Q2)
|
$1.14 | $1.11 | +0.0333 | +3.01% |
|
Mar 2025 (Q1)
|
$0.65 | $1.62 | -0.9708 | -59.90% |
Financial Statements
| Revenues | $163.00K |
| Benefits Costs and Expenses | $13.87M |
| Costs And Expenses | $13.87M |
| Operating Expenses | $13.87M |
| Depreciation and Amortization | $4.00K |
| Research and Development | $6.76M |
| Other Operating Expenses | $7.11M |
| Operating Income/Loss | -$13.70M |
| Income/Loss From Continuing Operations After Tax | -$13.70M |
| Income/Loss From Continuing Operations Before Tax | -$13.70M |
| Net Income/Loss | -$13.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$13.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$13.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 31,085,000 |
| Diluted Average Shares | 31,085,000 |
| Assets | $3.78M |
| Current Assets | $2.86M |
| Cash | $3.65M |
| Noncurrent Assets | $919.00K |
| Fixed Assets | $0.00 |
| Liabilities | $5.07M |
| Current Liabilities | $2.44M |
| Accounts Payable | $1.25M |
| Other Current Liabilities | $1.19M |
| Noncurrent Liabilities | $2.63M |
| Equity | -$1.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$1.29M |
| Liabilities And Equity | $3.78M |
| Net Cash Flow From Operating Activities | -$11.65M |
| Net Cash Flow From Operating Activities, Continuing | -$11.65M |
| Net Cash Flow From Investing Activities | $0.00 |
| Net Cash Flow From Financing Activities | $4.79M |
| Net Cash Flow From Financing Activities, Continuing | $4.79M |
| Net Cash Flow | -$6.86M |
| Net Cash Flow, Continuing | -$6.86M |
| Comprehensive Income/Loss | -$13.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$13.70M |
| Other Comprehensive Income/Loss | $0.00 |